UB
AMPH icon

UMB Bank’s Amphastar Pharmaceuticals AMPH Stock Holding History

UMB Bank’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.89K Buy
292
+112
+62% +$2.26K ﹤0.01% 2065
2026
Q1 		$3.53K Sell
180
-70
-28% -$1.71K ﹤0.01% 2094
2025
Q4 		$6.7K Buy
250
+3
+1% +$77 ﹤0.01% 1951
2025
Q3 		$6.58K Buy
247
+228
+1,200% +$5.89K ﹤0.01% 1813
2025
Q2 		$436 Sell
19
-208
-92% -$5.16K ﹤0.01% 2078
2025
Q1 		$6.58K Buy
227
+174
+328% +$5.56K ﹤0.01% 1683
2024
Q4 		$1.97K Sell
53
-50
-49% -$2.29K ﹤0.01% 1939
2024
Q3 		$5K Buy
103
+59
+134% +$2.59K ﹤0.01% 1730
2024
Q2 		$1.76K Buy
44
+28
+175% +$1.16K ﹤0.01% 1824
2024
Q1 		$703 Buy
+16
New +$826 ﹤0.01% 1890

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UMB Bank's AMPH Position: Q2 2026 in Review

UMB Bank increased its Amphastar Pharmaceuticals (AMPH) stake by 62% in Q2 2026, buying an estimated $2.26K and bringing the position to 292 shares worth $5.89K. The position accounts for ﹤0.01% of the portfolio, ranked #2065.

UMB Bank first reported a position in AMPH in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.7K in Q4 2025. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • UMB Bank held 292 shares of Amphastar Pharmaceuticals worth $5.89K as of Q2 2026.
  • UMB Bank bought 112 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $2.26K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #2065 holding.
  • UMB Bank first reported a position in Amphastar Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • UMB Bank's Amphastar Pharmaceuticals position peaked at $6.7K in Q4 2025.
  • 212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.